783-4 Follow-up Results of Transvenous Occlusion of Patent Ductus Arteriosus with the Adjustable Buttoned Device  by Rao, P. Syamasundar et al.
332A ABSTRACTS lACC February 1995
11 :00
1783-31 A New and Simple Method for Transcatheter
Occlusion of Patent Ductus Arteriosus and Residual
Shunts: Retrievable Coil Device
Trong-Phi Le. Malte Neuss. Dierk Redel. Hermann Weinzheimer. G,SO Behrwind.
Pediatric Cardiology, University Children's Hospital of Bonn. Germany
For occlusion of patent ductus arteriosus IPDA) the currently used coil
devices are not safe because of lack of deployment precision and re-
trievability. In 1992 we developed a new intravascular occlusion technique
using memory-shaped retrievable stainless steel coils (Duct-Occlud. Pfm.
Cologne). A snap-in mechanism keeps the coil attached to the core wire
before final detachment. The new occlusion technique, therefore enables
precise placement of coils.
We report first clinical results of transcatheter occlusion of PDA using the
new coil device. From November 1992 to August 1994 all patients (n = 59,
aged 4 months to 21 years, 4.5-64 kg) with a PDA underwent a transcatheter
occlusion procedure. In 52 patients a coil implantation was successful. A
balloon dilatation of a valvar pulmonary stenosis (n = 1) and a coarctation of
aorta (n = 1) was successfully performed in the same session of PDA occlu-
sion. In the remaining 7 patients coil implantation was not possible because
of too small (PDA-diameter < 0.5 mm, n = 4) or too large (smallest PDA-
diameter> 3 mm, n = 3) ductus size. The rate of total occlusion 6 months
after implantation was 88%. Early complete occlusion (within 24 hours) was
demonstrated in 39 cases (75%), delayed (within 6 months) occlusion in 7
(13%) cases. In 6 patients a residual shunt (1 moderate. 5 small) remained.
in 2 of them a second coil (coil-in-coil-technique) was implanted 1 year af-
ter first attempt with following complete occlusion within few minutes. In
all coil implantation procedures neither embolization of coils nor major com-
plications occurred. No flow disturbances in descending aorta or pulmonary
artery or mechanical hemolysis were registered.
Conclusion: Our first clinical results demonstrate the new transcatheter
coil occlusion technique as a highly effective and very safe method. This
technique seems to be the method of choice for occlusion of small and
medium sized PDA.
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1783-41 Follow-up Results of Transvenous Occlusion of
Patent Ductus Arteriosus with the Adjustable
Buttoned Device
P. Syamasundar Rao. Jorge Haddad. Christian Rey, Gerd Hausdort. Ann Worms.
Eustaquio Onorato. Ramesh Arora. Rajeev Lochan. P Seshagiri Rao. B.S. Raju.
Eleftherios 8. Sideris University of Wisconsin Medical School. Madison, WI
During a 4-year period ending July 1994. 81 patients underwenttranscatheter
occlusion of patent ductus arteriosus IPDA) with the adjustable buttoned de-
vice at 22 institutions around the world under an IRB-approved custom-made
device protocol. The device is a modified version of the Sideris' buttoned
device for atrial septal defect closure. The patients were 11 mo to 65 years
(median. 7.0 years) with weight range of 7.2 to 90 kg (median. 19 kg) The
PDAs measured 1 to 15 mm (median. 4 mm) at the narrowest diameter; fif-
teen were larger than 8 mm and three larger than 10 mm with a Op:Os range
of 1.3 to 3.2. They were occluded with devices measuring 15 to 35 mm; all
but 10 were delivered via #7-French sheaths. Ten devices :0: 25 mm were de-
livered to the implantation site via #8-French sheaths. 78 of 81 (96%) were
implanted at first attempt. In all three with device dislodgment, the device
was retrieved via the sheath and two of these underwent PDA occlusion with
larger devices and third patient had elective surgical closure of PDA. Small
residual shunts detected by color Doppler were present in 31 (39%) patients.
Forty-one patients were followed for 1 to 24 months (8 ± 7 mol with clini-
cal, chest x-ray and echo-Doppler evaluation. None required repeat interven-
tion. The device was found intact on chest x-ray and echo. No evidence for
thromboembolism, endocarditis or hemolysis was found nor was there ev-
idence for descending aortic or left pulmonary artery obstruction. Percent
incidence of residual shunt by color Doppler gradually decreased and was
39,21.15.13 and 0% respectively at 1 day. 1.6,12 and 24 months following
device implantation.
Based on these data it is concluded that 1) transvenous occlusion of PDA
is feasible, effective and safe, 2) small-sized sheaths (7-French in most, 8-
French in some) are adequate for all ductus sizes, 3) all types of PDAs (con-
ical, tubular and short) and both long and short PDAs can be occluded be-
cause of the adjustable button loop design of the device. 4) further improve-
mentlminiaturization may eventually result in extending the procedure to
neonates and premature infants.
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1783-51 Intravascular Stents in Systemic Venous and
Systemic Venous Baffle Obstructions
Cameron J.B. Ward. Charles E. Mullins. Michael R. Nihill, Ronald G. Grifka. G.
Wesley Vick III, Texas Children's Hospital Baylor College ofMedicine. Houston. TX
For the management of systemic venous and systemic venous baffle ob-
structions, both surgery and isolated balloon dilation of are often unreward-
ing. Since 1991 we have managed such obstructions with intravascular
stents. Twelve pts aged 3 mths-20 yrs Imean 8.2 yrs), have had 21 stents
implanted in 13 systemic venous obstructions: 9/13 in central veins and 4/13
post atrial baffles for TGA. 12/13 obstructions were acquired and 1/13 con-
genital. 8/13 obstructions were symptomatic (SVC syndrome 6/8) and 5/13
were asymptomatic.
Immediate Results: Obstruction was complete requiring transeptal needle
perforation in 4/13. Post-stent implantation, the diameter of the obstruction
increased from 2 ± 2.4 mm (range 0-8.5 mm) to 11.4 ± 3.7 mm (range 7.6-
20 mm, p < 0.001). The gradient decreased from 10.8 ± 8.1 mmHg (range
0-20 mmHg) to 0.9 ± 1.3 mmHg (range 0-4 mmHg, p < 0.001). There was
residual angiographic obstruction in 1/13 pts. Symptoms resolved in 6/8 and
improved in 2/8 symptomatic pts. No complications were incurred.
Fol/ow-up Results: 6/13 obstructions were restudied 2-13 mths post stent
implantation. All stents remain patent with no stent fracture or compression.
No stents required redilation. Neointimal hyperplasia was seen in 5/6 stents.
Differences between immediate post stent and follow-up lumen size (13 ±
4.7 mm vs 11 ± 4.7 mm) and gradients (1 ± 1.6 mmHg vs 0.7 ± 1.2 mmHg)
were not significant. In 1 pt. with 4 serial stents, 1 stent had 'unlocked' and
rotated, but remained unobstructed.
Conclusions: Stent implantation in systemic venous obstructions is safe
and effective. even where obstruction is complete. Longterm follow-up is
required to determine if neointimal proliferation will require redilation. We
postulate intravascular stents will become the treatment of choice for se-
lected systemic venous and systemic venous baffle obstructions.
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1783-61 Complications of Pediatric Cardiac Catheterization: A
Prospective Study
Renato Vitiello. David Nykanen, Lee N. Benson, Robert M. Freedom. The Hospital
for Sick Children. Toronto, Ontario, Canada
A study of adverse events related to diagnostic (DIAGN) or interventional (IN-
TERV) cardiac catheterizations was undertaken beginning January 1, 1987
through December 31, 1993 involving 4,952 studies. Patient ages ranged
from 1 day to 20.6 years. There were 1,472 (29.6%) INTERV procedures,
3,117 (62.7%) DIAGN (angiographic and hemodynamic) and 381 (7.7%) elec-
trophysiologic (EP) studies. A number of patients underwent both INTERV
and EP studies at the same procedure.
One or more complications were reported in 498 (10.1 %j patients. Major
complications (death n = 35, cardiac arrest n = 7, cardiac perforation n =
7, complete heart block n = 14, ventricular tachycardia or fibrillation n = 7)
were reported in 70 (1.4%) cases: 63% percent of deaths occurred in pts <
1 year old. Minor complications occurred in 476 cases including 183 (38.4%)
arterial complications. with residual pulse weakness after therapy in only 14
(2.9%) pts. The incidence of complications was 9.5% in DIAGN (56 major;
268 minor), 11.6% in INTERV (25 major; 164 minor), and 7.4% in EP studies
18 major; 29 minor). Age, type of cardiac catheterization and complications
are as follows:
Age All Patients DIAGN EP INTERV
# Compl./Total # Compl.lTotal # Compl.lTotal # Compl.lTotal
<1 mos 78/471 (16.5%) 59/3991148%) 119111.1%) 18/64128.1%)
1-6 mos 80/497 (16.1 %J 51/356114.3%) 0/910%) 29/135 (21.5%)
6 mos-1 yr 68/465 (150%) 49/352 (13.9%) 2/5140%) 17/109 (15.6%)
>1 yr 27113.519 (77%) 139/2.01016.9%} 26/35817.3%) 107/1.164(9.2%)
Pediatric cardiac catheterization is not a risk free procedure, and the inci-
dence of major complications is low. However, with incrising INTERV proce-
dures the incidence of major/minor complications may increase.
